Search Results

Displaying Results 6351-6375 of 11052 "'T'"

Mar 12, 2026, 10:01 ET Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight

(177Lu-PSMA-617, 225Ac‑PSMA‑617, 177Lu-NNS309, 177Lu-NeoB, AAA614, and ESP359), Curium Pharma (177Lu-PSMA-I&T), Lantheus and Eli Lilly and Company (Lu-PNT2002 and LNTH-1095), Fusion Pharmaceuticals and AstraZeneca (FPI-2265), Clarity Pharmaceuticals (67CU

More news about: DelveInsight Business Research, LLP


Mar 12, 2026, 10:00 ET Breakthrough T1D Chief Medical Officer Dr. Thomas Danne to be Honored with Children with Diabetes President's Award for Innovation

advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition.About type 1 diabetes (T1D)T1D is an autoimmune condition that causes the pancreas to make very little insulin

More news about: Breakthrough T1D, Formerly JDRF


Mar 12, 2026, 10:00 ET Eoptolink Demos IMDD 400G per Lambda Based 1.6T DR4 Optical Transceiver Solution at OFC 2026

reflected in the roadmap for high-speed optical transceivers, progressing toward 800G, 1.6T, and 3.2T.Currently, 100G/lambda-based 800G optical transceivers are being deployed in high volumes, while 200G/lambda-based 1.6T products are ramping up. At the same time, the industry is accelerating the development

More news about: Eoptolink Technology Inc., Ltd.


Mar 12, 2026, 10:00 ET T. ROWE PRICE LAUNCHES ITS FIRST EMERGING MARKETS EQUITY ETF OFFERING

lineup expands to 32 with today's addition of the T. Rowe Price Emerging Markets Equity Research ETF, which began trading todayBALTIMORE, March 12, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm

More news about: T. Rowe Price Group


Mar 12, 2026, 10:00 ET Eoptolink Joins XPO MSA and Unveils Industry-First 12.8 Tbps Liquid-Cooled Pluggable Optics for AI Data Centers

optical interconnect solutions for AI infrastructure and cloud data centers.Eoptolink will be showcasing its latest 12.8T XPO, 400G/lambda-1.6T DR4, and 200G/lambda-1.6T FRO/LRO/LPO series optical transceiver solutions at the Eoptolink booth #1211 during OFC 2026 in Los Angeles, CA. Visitors are

More news about: Eoptolink Technology Inc., Ltd


Mar 12, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR

to treat autoimmune disorders. The Company's lead product candidateis rezpegaldesleukin (a/k/a REZPEG or NKTR-358), a novel, first-in-class regulatory T cell stimulator for the treatment of, inter alia, alopecia areata.In March 2024, Nektar initiated its Phase 2b REZOLVE-AA trial, which was

More news about: Pomerantz LLP


Mar 12, 2026, 09:52 ET /C O R R E C T I O N -- Phemex/

More news about: Phemex


Mar 12, 2026, 09:42 ET NewPhotonics® Introduces Industry First 3.2Tbps DR8 Transmitter-on-Chip PIC with Integrated OSPic™ Optical Signal Processor for AI Data Center Connectivity

lane. "AI clusters are rapidly driving the transition to higher-speed optical interconnects, with the industry moving from 800G and 1.6T to 3.2T in the next phase of scaling," said Vlad Kozlov, Founder, LightCounting. "Highly integrated photonic engines that combine lasers, modulators

More news about: NewPhotonics Ltd


Mar 12, 2026, 09:38 ET NKTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026

induction treatment period of the Phase 2b REZOLVE-AA trial of investigational rezpegaldesleukin, a first-in-class IL-2 pathway agonist and regulatory T-cell (Treg) proliferator."  The press release disclosed that the trial failed to reach statistical significance, which Nektar attributed to the inclusion

More news about: Faruqi & Faruqi, LLP


Mar 12, 2026, 09:26 ET 醫學人工智能研討會推動負責任的運用與創新

醫學博士、哲學博士說:「我們希望分享耶魯及其他機構正在進行、非常振奮人心的研究。 我們將討論在轉化研究(即快將應用到醫療服務的研究)中,開發、評估和應用 AI 等重要議題的最佳實踐方案,並計劃開展合作,攜手推進我們現有的工作。」是次研討會旨在促進耶魯大學校內不同的研究團隊,與其他機構的研究團隊建立聯繫。 耶魯醫學院 Robert T. McCluskey 生物醫學資訊學與數據科學教授兼研討會聯合創辦人 Hua Xu 博士說:「屆時將有講者探討 AI 在臨床的實際應用,例如怎樣將

More news about: Yale School of Medicine


Mar 12, 2026, 09:15 ET A2GOLD OUTLINES 2026 EXPLORATION PLANS TO EXPAND SILVER AND GOLD RESOURCES AT THE TAYLOR PROJECT, NEVADA

corridorChannel samples returning up to 4.2 g/t gold over 11.0 meters, including 7.1 g/t gold over 3.3 metersSPT-66 intersected 1.02 g/t gold over 18.3 meters starting at surfaceSPT-65 intersected 0.68 g/t gold over 24.4 meters starting at surface including 0.85 g/t gold over 12.2 metersQUALIFIED

More news about: A2 Gold Corp


Mar 12, 2026, 09:15 ET NatGold Digital Signs $20M Definitive Agreement to Acquire Historic Idaho Gold Project, Targeting 73% Token Minting Share

exploration and development dating back more than a century.The project area lies within multiple township sections spanning T28N R8E, T28N R7E, T27N R8E, T27N R7E, and T26N R7E, with the geographic center located at 2,013,054 Easting and 16,607,230 Northing (NAD83, Zone 11 BLM US Feet). Mapping coverage

More news about: NatGold Digital Ltd.


Mar 12, 2026, 09:01 ET MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035

pre-clinical animal models of MASH and T2D where vanoglipel reduced hepatic steatosis, inflammation, fibrosis, and improved glucose control. Furthermore, in Phase 1a, 1b and 2a trials, vanoglipel was well tolerated in both healthy volunteers and those with T2DM. In a Phase 2a clinical study, vanoglipel

More news about: MetaVia Inc.


Mar 12, 2026, 09:00 ET Apex Media Partners Brings In Touch+ Biblical Programming to Comcast Northeast

Hartford, Pittsburgh, and Manchester. For non-Comcast subscribers, In Touch+ can be accessed on a variety of other platforms like DIRECTV®, AT&T U-verse, Amazon Prime, Xumo Play, and more.To learn more about In Touch Ministries and find where to watch, visit

More news about: Apex Media Partners


Mar 12, 2026, 09:00 ET Crunch Franchise Brings State-of-the-Art Crunch 3.0 Gym to Fort Wayne, Indiana

and to sign up. Crunch Fort Wayne offers the first 500 founding members to lock in their rate will receive $1 down, one month free, a complimentary t-shirt, discounts on small group and personal training and more.Crunch is also expanding its team within Fort Wayne and is looking for individuals

More news about: Crunch Fitness


Mar 12, 2026, 08:20 ET Swayable CEO Appointed to Advertising Research Foundation Board of Trustees

major brands as the gold standard evidence of creative impact, that is, lift caused in consumer attitudes. Major brands, including Amazon, Airbnb, T-Mobile, DoorDash, and Paramount use Swayable to deploy creative tests.About James SlezakDr. James Slezak is the Founder and

More news about: Swayable


Mar 12, 2026, 08:00 ET Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

study across 28 countries; 27–28% reached individualized A1C targets.)7 Data on file, Abbott Diabetes Care. $217B based on internal T2D/basal insulin cost modeling.8 Wilmot E. G. BMJ Open (2025).

More news about: Abbott


Mar 12, 2026, 07:58 ET Pierre Fabre Pharmaceuticals Announces Type A Meeting Agreed with U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA)

announces the U.S. Food and Drug Administration (FDA) has agreed to Type A meeting for the biologic license application for tabelecleucel, an allogeneic T-cell therapy with a proposed indication for relapsed/refractory (R/R) Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD).

More news about: Pierre Fabre Pharmaceuticals


Mar 12, 2026, 07:00 ET Alliance Reports Fourth Quarter and Full Year 2025 Results

invest at scale in 2025:Extended ProCapture lint filtration technology across a broader range of productsLaunched the T55 stack tumbler, the industry's largest at 55 poundsIntroduced Scan-Pay-Wash, the industry's first app-less cashless payment solutionLaunched

More news about: Alliance Laundry Systems


Mar 12, 2026, 06:30 ET VIAVI Launches TestCenter D2 1.6T Appliance to Accelerate AI Infrastructure Rollouts Across Hyperscale and Cloud Data Center Environments

launch of the TestCenter D2 1.6T Appliance helps change this, giving customers the confidence they need in the speed, reliability and interoperability of new 1.6T-class networks."In addition to supporting the latest 1.6T Ethernet technologies, the TestCenter D2 1.6T Appliance implements multi-rate

More news about: VIAVI Solutions


Mar 12, 2026, 06:30 ET Full Truck Alliance Co. Ltd. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

Online Registration:https://s1.c-conf.com/diamondpass/10053167-hy76t5.htmlUpon registration, each participant will receive details for the conference call, including dial-in numbers and a unique

More news about: Full Truck Alliance Co. Ltd.


Mar 12, 2026, 06:15 ET Epson Robots to Showcase Scalable Retail Automation at Shoptalk Spring 2026

T-Series All-in-One SCARA robots offer a cost-effective, easy-to-deploy alternative to traditional slide-based systems with a compact footprint suited

More news about: Epson America, Inc.


Mar 12, 2026, 06:14 ET Beijing Review: Coding a Greener Future

http://www.bjreview.com/Multimedia/Video/Wisdom_Without_Borders/202603/t20260310_800432560.html Weibohttps://weibo.com/1719349955/QvoYTma9s

More news about: Beijing Review


Mar 12, 2026, 04:58 ET Moomoo's Parent Company Futu Achieves Consecutive Growth in Q4 and Full Year 2025

public equity issued in blockchain-native form.In Singapore, the Company introduced CDP-linked trading of SGX-listed stocks and first launched the T+1 FTGF Franklin Ultra Short Duration Income Fund. The Company also expanded the Cash Sweep eligibility to a broader user access in the US.For cryptocurrency

More news about: moomoo


Mar 12, 2026, 03:00 ET Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

study across 28 countries; 27–28% reached individualized A1C targets.)7 Data on file, Abbott Diabetes Care. $217B based on internal T2D/basal insulin cost modeling.8 Wilmot E. G. BMJ Open (2025).

More news about: Abbott


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.